Diagnosis and successful in utero treatment of a fetal goitrous hyperthyroidism caused by maternal graves’ disease

Fetal Diagnosis and Therapy

Volumn 12, Issue 1, 1997, Pages 54-58

  Heckel, S ^a   Favre, R ^a   Schlienger, J L ^a   Soskin, P ^a  

^a HÔPITAL DE HAUTEPIERRE   (France)

Author keywords

Fetal blood sampling; Fetal goiter; Fetal therapy; Fetal thyrotoxicosis; Graves disease; Hyperthyroidism; Prenatal diagnosis

Indexed keywords

CARBIMAZOLE; PROPRANOLOL; PROPYLTHIOURACIL; THYROXINE;

ADULT; ARTICLE; CASE REPORT; EUTHYROIDISM; FEMALE; FETUS BLOOD; FETUS ECHOGRAPHY; GOITER; GRAVES DISEASE; HUMAN; HYPERTHYROIDISM; MATERNAL DISEASE; PATHOGENESIS; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; SUBSTITUTION THERAPY; SUBTOTAL THYROIDECTOMY; THYROTOXICOSIS;

ADULT; ANTITHYROID AGENTS; CARBIMAZOLE; FEMALE; FETAL BLOOD; FETAL DISEASES; GOITER; GRAVES DISEASE; HUMANS; HYPERTHYROIDISM; PREGNANCY; PREGNANCY COMPLICATIONS; THYROIDECTOMY; ULTRASONOGRAPHY, PRENATAL;

EID: 0030943403     PISSN: 10153837     EISSN: 14219964     Source Type: Journal    
DOI: 10.1159/000264428     Document Type: Article

References (30)

1. Check JH, Rezvani I, Goodlier D, Hopper B: Prenatal treatment of thyrotoxicosis to prevent intrauterine growth retardation. Obstet Gynecol 1982:60:122-124.
2. Vali A, Wiles P, Thomas NB, Ludlam A: Relapse of maternal thyreotoxicosis presenting as a second trimester fetal goiter. Ultrasound Obstet Gynecol 1993;3:429-431.
3. Wenstrom KD, Weiner CP, Williamson RA, Grant SS: Prenatal diagnosis of fetal hyperthyroidism using funipuncturc. Obstet Gynecol 1990;76:513-517.
4. Ferclman AH, Clemons RD: The fetus in maternal hyperthyroidism. Thyroid 1992:2:225-228.
5. Hatjis CG: Diagnosis and successful treatment of fetal goitrous hyperthyroidism caused by maternal Graves’ disease. Obstet Gynecol 1993;81:837-839.
6. Porreco RP, Bloch CA: Fetal blood sampling in the management of intrauterine thyrotoxicosis. Obstet Gynecol 1990;76:509-512.
7. Lcwin F, Toublanc JE, Landowski P: Pathologie thyroidienne fœtale; in Les traitements médicamenteux du fœtus. Paris, Springer. 1995, pp 81-97.
8. Belfar HL, Foley TP, Hill LM, Kislak S: Sonographic findings in maternal hyperthyroidism, fetal hyperthyroidism/fetal goiter. J Ultrasound Med 1991;10:281-284.
9. Bruinse HW, Vermeulen-Weiner C, Wit JM: Fetal treatment for thyrotoxicosis in nonthyro-toxic pregnant women. Fetal Ther 1988:3:152-157.
10. Burrow NG: The management of thyrotoxicosis in pregnancy. N Engl J Med 1985:313:562.
11. Zakarya M, MacKcnzic JM, Hoffman WH: Prediction and therapy of intrauterine and late-onset neonatal hyperthyroidism. J Clin Endocrinol Metab 1986:62:368-371.
12. Bromley B, Frigoletto FD, Cramer D, Osatha nondt R, Benaccrraf BR: The fetal thyroid: Normal and abnormal measurements. J Ultrasound Med 1992:11:25-28.
13. Weiner S, Scharf JI, Bolognese RJ, Librizzi RJ: Antenatal diagnosis and treatment of a fetal goiter. J Rcprod Med 1980:24:39-42.
14. Pekonen F, Teramo K, Makinen T, Ikonen E, Osterlund K, Lamberg BA: Prenatal diagnosis and treatment of fetal thyrotoxicosis. Am J Obstet Gynecol 1984,150:893-894.
15. Pradeep VM, Ramachandran K, Sulhcka C: Fetal goiter: A case detected by ultrasonography. J Clin Ultrasound 1991:19:571-574.
16. Van Loon AJ, Derksen JT, Bos AF, Rouwe CW: In utero diagnosis and treatment of fetal goitrous hypothyroidism caused by maternal use of propylthiouracil. Prenat Diagn 1995,15: 599-604.
17. Van de Merckt C, Avni EF, Von Lennep E, Rodcsch F: Goitre fœtal: dépistage et suivi échographique. Pédiatrie 1990:45:323-326.
18. Avni EF, Rodesch F, Van de Merkt C, Ver-meylen D: Detection and evaluation of fetal goiter by ultrasound. BrJ Radiol 1992:65:302-305.
19. Burrow GN, Fischer DA, Larsen PR: Maternal and fetal thyroid function. N Engl J Med 1994; 331:1072-1077.
20. Davidson KM, Richard DS, Schatz AD, Fisher DA: Successful in utero treatment of fetal goiter and hypothyroidism. N Engl J Med 1991; 124:543-546.
21. Hadi HA, Strickland D: Prenatal diagnosis and management of fetal goiter caused by maternal Graves’ disease. Am J Perinatol 1995; 12:240-242.
22. Ballabio M, Nicolini U, Jowett T, Ruiz de Elvira MC, Ekins RP, Rodeck CH: Maturation of thyroid function in normal human fetuses. Clin Endocrin 1989:31:565-571.
23. Thorpc-Bceston JG, Nicolaides KH, MacGregor AM: Fetal thyroid function. Thyroid 1992; 2:207-217.
24. MacKcnzic JM, Zakarija M: Fetal and neonatal hyperthyroidism and hypothyroidism due to maternal TSH receptor antibodies. Thyroid 1992;2:155-159.
25. Kasiji K, Iida I, Konishi J: Paired determination of thyroid-stimulating and TSH-binding inhibitor activities in patients with Graves’ disease curing antithyroid drug treatment. Acta Endocrinol 1986;111:474-480.
26. Volpe R, Karlsson A, Jansson R, Dahlberg PA: Evidence that antithyroid drugs induce remissions in Graves' disease by modulation thyroid cellular activity. Clin Endocrinol 1986,25:453-462.
27. Gardner DF, Cruikshank DP, Hays PM, Cooper PS: Pharmacology of PTU in pregnant hy-perthvroid women: Correlation of maternal PTU concentrations with cord serum thyroid function tests. J Clin Endocrinol Metab 1986; 62:217-220.
28. Wallace C, Couch R, Ginsberg J: Fetal thyreotoxicosis: A case report and recommendation for prediction, diagnosis and treatment. Thyroid 1995;5:125-128.
29. Polak M, Leger J, Czcrnichow P: Hypcrthy-roi'dics du nouveau né. Journées Parisiennes de Pédiatrie. Paris. Flammarion Médecine Science. 1995, pp 249-257.
30. Skusa KA, Sills IN, Stene M, Rapaport R: Prediction of neonatal hyperthyroidism in infants born to mothers with Graves' disease. J Pediatr 1996:128:264-267.